Abstract
A library of new thalidomide analogues containing an olefin functionality were synthesised using a Heck cross coupling reaction from their aryl halogenated precursor. All analogues were tested for their ability to inhibit the synthesis of the proinflammatory cytokine Tumour Necrosis Factor (TNF). Compounds 22, 29, 33 and 37 were the most effective in this assay inhibiting TNF expression 50%, 69%, 52% and 50%, respectively. Crown copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 5819-5824 |
| Journal | Bioorganic & medicinal chemistry letters |
| Volume | 17 |
| Issue number | 21 |
| DOIs | |
| Publication status | Published - 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Synthesis and TNF expression inhibitory properties of new thalidomide analogues derived via Heck cross coupling'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver